Benzinga's Top #PreMarket Gainers By: Benzinga via Benzinga June 05, 2014 at 08:10 AM EDT Halozyme Therapeutics (NASDAQ: HALO) shares gained 13.86% to $9.20 in pre-market trading after the company reported that it will resume ... Read More >> Related Stocks: Ciena Corp Five Below Inc Halozyme Therapeutic Verint Systems Inc